|
Multiple sclerosis
Citations 421-430 of 475 total displayed.
|
Past content
(since Jan 2001):
|
- BRIEF COMMUNICATIONS
Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS
- A. Traboulsee, J. Dehmeshki, P. A. Brex, C. M. Dalton, D. Chard, G. J. Barker, G. T. Plant, and D. H. Miller
Neurology 2002; 59: 126-128.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Neutralizing antibodies reduce MxA protein induction in interferon- beta-1a-treated MS patients
- A.-M. Vallittu, M. Halminen, J. Peltoniemi, J. Ilonen, I. Julkunen, A. Salmi, J.-P. Erälinna, and the Finnish Beta-Interferon Study Group
Neurology 2002; 58: 1786-1790.
[Abstract]
[Full text]
[PDF]
- NEUROIMAGES
Painful third nerve palsy in MS
- P.I. Bentley, T. Kimber, and A.H.V. Schapira
Neurology 2002; 58: 1532.
[Full text]
[PDF]
- EDITORIALS
Cannabinoids in MS: Potentially useful but not just yet!
- Alan J. Thompson and David Baker
Neurology 2002; 58: 1323-1324.
[Full text]
[PDF]
- ARTICLES
Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit
- E. Silber, Y. K. Semra, N.A. Gregson, and M. K. Sharief
Neurology 2002; 58: 1372-1381.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Safety, tolerability, and efficacy of orally administered cannabinoids in MS
- J. Killestein, E. L.J. Hoogervorst, M. Reif, N. F. Kalkers, A. C. van Loenen, P. G.M. Staats, R. W. Gorter, B. M.J. Uitdehaag, and C. H. Polman
Neurology 2002; 58: 1404-1407.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
A one-year study on the pharmacodynamic profile of interferon-ß1a in MS
- F. Bagnato, C. Pozzilli, C. Scagnolari, F. Bellomi, P. Pasqualetti, C. Gasperini, E. Millefiorini, S. Galgani, M. Spadaro, and G. Antonelli
Neurology 2002; 58: 1409-1411.
[Abstract]
[Full text]
[PDF]
- VIEWS & REVIEWS
MRI techniques to monitor MS evolution: The present and the future
- Massimo Filippi and Robert I. Grossman
Neurology 2002; 58: 1147-1153.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Quantitative functional measures in MS: What is a reliable change?
- S. R. Schwid, A. D. Goodman, M. P. McDermott, C. F. Bever, and S. D. Cook
Neurology 2002; 58: 1294-1296.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Randomized pilot study of nimesulide treatment in Alzheimer’s disease
- P. S. Aisen, J. Schmeidler, and G. M. Pasinetti
Neurology 2002; 58: 1050-1054.
[Abstract]
[Full text]
[PDF]
|
|
